Loading company…
Theranica Bio-Electronics Ltd makes Nerivio, a wearable device for drug-free migraine and neurological pain relief.
Founded in 2016 and headquartered in Netanya, Israel, Theranica develops wearable medical devices, with its flagship Nerivio using remote electrical neuromodulation for migraine and other neurological pain. Products are sold to patients and healthcare providers in North America, Europe and parts of Asia, and the device requires a prescription. The company raised USD 45 mn in a Series C round on August 29, 2022, led by New Rhein Healthcare Investors.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in